# Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis

> **NCT00432653** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 20 (—)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** rituximab

## Key facts

- **NCT ID:** NCT00432653
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** 2009-11
- **Target enrollment:** 20 (—)
- **Last updated:** 2007-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432653, "Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00432653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*